Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 receptor agonists have become popular for weight loss, but approximately 15–20% of candidates are excluded due to medical contraindications or safety concerns. Understanding who should not take these medications is essential before starting treatment, and PlexusDx helps identify whether you qualify for semaglutide or need a different precision approach.

Personal or Family History of Medullary Thyroid Cancer

GLP-1 medications carry a black-box warning for medullary thyroid carcinoma (MTC) based on animal studies showing C-cell proliferation in rodent models. Anyone with a confirmed history of MTC or multiple endocrine neoplasia type 2 (MEN2) syndrome should not use semaglutide, tirzepatide, or similar compounds.

This contraindication extends to first-degree relatives with MTC or MEN2, since genetic predisposition increases personal risk. Your initial consultation should always include a detailed family history of thyroid cancer, endocrine tumors, or hereditary cancer syndromes to rule out this serious risk factor before starting any GLP-1 therapy.

Severe Diabetic Retinopathy and Uncontrolled Blood Sugar

Patients with severe non-proliferative or proliferative diabetic retinopathy may experience temporary worsening of vision when taking GLP-1 drugs, particularly if blood sugar drops too quickly. This risk is highest in people with poorly managed diabetes or rapid glycemic control changes, making close monitoring essential before treatment begins.

PlexusDx recommends ophthalmologic evaluation before starting semaglutide if you have any history of diabetic eye disease. Your eye doctor and primary care provider should collaborate to ensure safe dosing and prevent complications that could affect your vision during weight loss.

Pancreatitis, Gallbladder Disease, and Gastrointestinal Disorders

A history of acute pancreatitis is a relative or absolute contraindication depending on severity and cause. GLP-1 medications slow gastric emptying and can increase pancreatitis risk in susceptible individuals, making past inflammation a red flag that requires specialist clearance before treatment approval.

Severe inflammatory bowel disease (Crohn's disease or ulcerative colitis), gastroparesis, or bowel obstruction also disqualifies many candidates, since semaglutide can worsen nausea, constipation, or abdominal pain in these populations. Gallbladder disease and a history of gallstones may increase the risk of acute cholecystitis during rapid weight loss, requiring preventive strategies or alternative therapies.

Pregnancy, Breastfeeding, and Certain Medications

Semaglutide is category C in pregnancy and not recommended for use during conception attempts, pregnancy, or breastfeeding due to limited safety data in human reproduction. Women of childbearing age must commit to effective contraception and stop the medication at least 2 months before attempting pregnancy.

Certain medications interact dangerously with GLP-1 therapy, including insulin and sulfonylureas (which increase hypoglycemia risk), warfarin (which may require dose adjustment), and some antidepressants. Always disclose your complete medication list during your initial assessment so PlexusDx can identify conflicts and recommend safe alternatives if needed.

When PlexusDx Offers Personalized Solutions Beyond Semaglutide

If you do not qualify for standard semaglutide, PlexusDx offers multiple pathways to safe, effective weight loss through the Precision Peptide Genetic Test. This peptide-pathway test maps 14 metabolic pathways and 49 peptides to reveal whether your genetics support alternative GLP-1 compounds, microdose protocols, or dual-compound therapies.

Compounded Semaglutide Injection starts at $149 per month for those who qualify, but PlexusDx also provides Oral Semaglutide, Tirzepatide Injection and Oral formulations, and the GLP-Squared dual-compound options—all from licensed 503A compounding pharmacies with no insurance required and HSA/FSA eligibility. The Precision Peptide Genetic Test ($99 add-on after your first month) identifies which peptide pathways your body responds to best, ensuring you receive the most effective therapy for your unique biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the most common reason someone cannot take semaglutide?

Medullary thyroid cancer history or MEN2 syndrome is the primary absolute contraindication. Uncontrolled diabetes with severe diabetic retinopathy is the second most common reason for exclusion. PlexusDx conducts detailed screening during intake to identify these risk factors early.

Can I take semaglutide if I have gallstones?

Gallstones themselves are not an absolute contraindication, but rapid weight loss increases acute cholecystitis risk in patients with biliary disease. Your healthcare provider may recommend monitoring, a slower dose progression, or preventive measures. PlexusDx coordinates with your doctor to ensure safe dosing if you have a history of gallbladder problems.

What happens if I have pancreatitis history—am I disqualified forever?

Acute pancreatitis history requires specialist evaluation before any GLP-1 therapy. If your pancreatitis was alcohol-related or gallstone-related and has resolved, cautious treatment with monitoring may be possible. PlexusDx requires gastroenterology or hepatology clearance in these cases to protect your safety.

Can I use semaglutide while taking insulin for diabetes?

Semaglutide and insulin together significantly increase hypoglycemia (low blood sugar) risk, making this combination dangerous without close medical supervision and insulin dose reduction. Your doctor may need to switch you to a different diabetes medication before starting GLP-1 therapy, or use a carefully monitored microdose protocol.

How does the PlexusDx Precision Peptide Genetic Test help if I am excluded from semaglutide?

The test analyzes your GIPR, GLP1R, FTO, and MC4R genetic variants to reveal which peptide pathways your body responds to most effectively. If standard semaglutide is unsafe for you, the results guide PlexusDx providers toward alternative compounds, dosing schedules, or combination therapies with a higher success rate for your specific genetics. The test costs $99 as an add-on after your first month of treatment.

Is PlexusDx semaglutide FDA-approved?

PlexusDx compounds semaglutide through licensed 503A compounding pharmacies, which are regulated by state pharmacy boards and the FDA. Compounded medications are not FDA-approved in the traditional sense, but they are legally prescribed, legally dispensed, and covered by HSA/FSA accounts. All PlexusDx medications start at $149–$149 per month with no insurance required.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves